A Trial of Intravenous HRS-8427 in the Treatment of Adults With Complicate Urinary Tract Infection, Including Acute Pyelonephritis

NCT06144060 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

126

Enrollment

INDUSTRY

Sponsor class

Conditions

Patients With Complicated Urinary Tract Infection(cUTI), Including Acute Pyelonephritis(AP)

Interventions

DRUG: HRS -8427
DRUG: Imipenem and Cilastatin Sodium

Sponsor

Jiangsu HengRui Medicine Co., Ltd.